-
Global Biopharma Layoffs March 2026
Layoffs
Global Biopharma companies including Merck, Baye, and Novartis announce workforce reductions in March 2026 as part of cost-saving and strategic realignments, impacting research, technology, and leadership roles across their operations.
-
Global Biopharma Layoffs November 2025
Layoffs
This article tracks recent biotech and pharma layoffs, including major workforce cuts at Novo Nordisk, Takeda, GSK, Pharming, and others, as companies restructure operations, streamline pipelines, and refocus resources amid shifting market conditions.
-
Bayer $1.3 Billion Collaboration Agreement
Bayer
Bayer and Kumquat Biosciences announce a $1.3 billion global collaboration to develop and commercialize a KRAS G12D inhibitor, aiming to offer new treatment options for pancreatic, colorectal, and lung cancer patients.
-
-
-
-
-
Bayer's 2024 Financial report
Financial statements
Bayer's 2024 financial report reveals a 2.2% revenue decline, 6,908 job cuts, and ongoing legal battles. With strategic shifts and heavy R&D investment, the company faces challenges and opportunities ahead. Can Bayer turn the tide by 2025?
-
-
崇左市|
海口市|
云浮市|
恩施市|
孝昌县|
宁波市|
彩票|
罗平县|
新乡市|
枣庄市|
图片|
凤山县|
库伦旗|
仁怀市|
象山县|
弥勒县|
东宁县|
夹江县|
丰县|
威远县|
怀来县|
武穴市|
台湾省|
无棣县|
山丹县|
鄂尔多斯市|
吉林省|
德保县|
花莲县|
尤溪县|
德钦县|
怀柔区|
讷河市|
新化县|
三穗县|
板桥市|
原平市|
光泽县|
上思县|
麻江县|
延长县|